DreamWear Silicone Pillows Are Designed Using 3D Facial Scan Data to Fit Diverse Populations

December 8, 2020

DreamWear Silicone Pillows, an all-silicone pillow cushion, was designed using data from thousands of 3D facial scans to anatomically conform to fit and seal various nostril shapes and sizes across populations.

Aiming to address mask refit and therapy adherence challenges for both patients and providers, DreamWear Silicone Pillows is the latest addition to Philips’ modular DreamWear platform designed to simplify set-up by offering multiple cushion options on one mask frame.  This modularity allows for easy and efficient exchange of cushions during tirtrations with minmal disruptions during the setup process. The unique, data-driven design of DreamWear Silicone Pillows is now available for sizing via Philips Mask Selector, a pairing that helps to reduce costs associated with fitting time and mask waste.

Pamela Hall, Sleep Category Leader at Philips said, “Through a combination of addressing customer feedback and data-driven design, we continue to grow our Dream Family with more options that offer an unmatched holistic experience when it comes to CPAP mask comfort, fit, convenience and efficiency.”

“In order to help patients adhere to their sleep apnea therapies, it is critical that we continue to innovate and create solutions to effectively address patient compliance challenges,” said Pamela Hall, Sleep Category Leader at Philips. “Through a combination of addressing customer feedback and data-driven design, we continue to grow our Dream Family with more options that offer an unmatched holistic experience when it comes to CPAP mask comfort, fit, convenience and efficiency. These can be paired with solutions like Mask Selector to help clinicians and our medical equipment partners to fit patients effectively, keep patients comfortable, optimize performance, and promote therapy outcomes.” 

The new pillows cushion combines data from Philips’ advanced 3D facial scan technology with a unique, all-silicone design to help reduce pressure points inside the nostril. This innovative approach offers both comfort and an effective fit and seal, an ideal combination for therapy acceptance and adherence, particularly when paired with DreamWear’s convenient modular interchangeability. Philips’ new silicone pillows mask is the lightest tube-on-top pillows mask available today

The DreamWear Silicone Pillows joins the Philips Dream Family – a portfolio of solutions designed to help improve long-term patient outcomes by providing comfortable and effective sleep apnea therapy. Now available in North America, the new cushion solution will expand to additional markets in 2021.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”